Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 386

1.

Esophageal cancer: adjuvant therapy.

Ku GY, Ilson DH.

Cancer J. 2007 May-Jun;13(3):162-7. Review.

PMID:
17620765
2.

Preoperative therapy in esophageal cancer.

Ku GY, Ilson DH.

Clin Adv Hematol Oncol. 2008 May;6(5):371-9. Review.

PMID:
18516027
3.

Cancer of the gastroesophageal junction: Current therapy options.

Ilson DH.

Curr Treat Options Oncol. 2006 Sep;7(5):410-23. Review.

PMID:
16904058
4.

Preoperative and adjuvant therapies for upper gastrointestinal cancers.

Varadhachary G, Ajani JA.

Expert Rev Anticancer Ther. 2005 Aug;5(4):719-25. Review.

PMID:
16111471
5.

Cancer of the gastroesophageal junction: combined modality therapy.

Ilson DH.

Surg Oncol Clin N Am. 2006 Oct;15(4):803-24. Review.

PMID:
17030275
6.

Role of neoadjuvant therapy for esophageal adenocarcinoma.

Ku GY, Ilson DH.

Surg Oncol Clin N Am. 2009 Jul;18(3):533-46. doi: 10.1016/j.soc.2009.03.004. Review.

PMID:
19500742
7.

Preoperative therapy for esophageal cancer.

Ku GY, Ilson DH.

Gastroenterol Clin North Am. 2009 Mar;38(1):135-52, ix. doi: 10.1016/j.gtc.2009.01.012.

PMID:
19327572
8.

Gastroesophageal junction adenocarcinoma.

Swisher SG, Pisters PW, Komaki R, Lahoti S, Ajani JA.

Curr Treat Options Oncol. 2000 Dec;1(5):387-98. Review.

PMID:
12057146
9.

The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma.

Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Wu TT, Swisher SG.

Cancer. 2006 Sep 1;107(5):967-74.

10.

Adjuvant therapy for noncolorectal cancers.

Ilson DH.

Curr Opin Oncol. 2001 Jul;13(4):287-90. Review.

PMID:
11429487
11.

Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction.

Stahl M, Walz MK, Stuschke M, Lehmann N, Meyer HJ, Riera-Knorrenschild J, Langer P, Engenhart-Cabillic R, Bitzer M, Königsrainer A, Budach W, Wilke H.

J Clin Oncol. 2009 Feb 20;27(6):851-6. doi: 10.1200/JCO.2008.17.0506. Epub 2009 Jan 12.

PMID:
19139439
12.

Multimodality therapy of local regional esophageal cancer.

Kelsen DP.

Semin Oncol. 2005 Dec;32(6 Suppl 9):S6-10. Review.

PMID:
16399422
14.

Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancer.

Blanke CD, Choy H, Teng M, Beauchamp RD, Leach S, Roberts J, Washington K, Johnson DH.

Semin Radiat Oncol. 1999 Apr;9(2 Suppl 1):43-52.

PMID:
10210539
15.

Neoadjuvant therapy of esophageal cancer.

Ilson DH, Bains M, Ginsberg RJ, Kelsen DP.

Surg Oncol Clin N Am. 1997 Oct;6(4):723-40. Review.

PMID:
9309090
16.

Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS).

van Heijl M, van Lanschot JJ, Koppert LB, van Berge Henegouwen MI, Muller K, Steyerberg EW, van Dekken H, Wijnhoven BP, Tilanus HW, Richel DJ, Busch OR, Bartelsman JF, Koning CC, Offerhaus GJ, van der Gaast A.

BMC Surg. 2008 Nov 26;8:21. doi: 10.1186/1471-2482-8-21.

17.

Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junction.

Ku GY, Ilson DH.

Expert Rev Anticancer Ther. 2008 Dec;8(12):1953-64. doi: 10.1586/14737140.8.12.1953. Review.

PMID:
19046115
18.

Neoadjuvant and adjuvant chemotherapy for esophageal adenocarcinoma.

Mooney MM.

J Surg Oncol. 2005 Dec 1;92(3):230-8. Review.

PMID:
16299790
19.

Systemic treatment of oesophageal cancer.

Richel DJ, Vervenne WL.

Eur J Gastroenterol Hepatol. 2004 Mar;16(3):249-54. Review.

PMID:
15195887
20.

[Neoadjuvant therapy for resectable esophageal cancer].

Hejna M, Raderer M.

Z Gastroenterol. 2005 Oct;43(10):1141-7. Review. German.

PMID:
16220454

Supplemental Content

Support Center